Dr. Berry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 Macon Pond Dr
Raleigh, NC 27607Phone+1 919-781-7070
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1975 - 1979
- Duke University HospitalResidency, Internal Medicine, 1974 - 1974
- Duke University School of MedicineClass of 1974
Certifications & Licensure
- MN State Medical License 2024 - 2025
- NC State Medical License 1976 - 2025
- HI State Medical License 1987 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Coh...Evan Y Yu, Cristiano Ferrario, Mark D Linch, Michael Stoeckle, Brigitte Laguerre
European Urology Oncology. 2024-06-25 - Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 ...Evan Y Yu, William R Berry, Howard Gurney, Margitta Retz, Henry J Conter
European Urology Oncology. 2024-06-01 - Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman, Susan Halabi, Lauren E Howard
Prostate Cancer and Prostatic Diseases. 2024-02-22
Press Mentions
- 1973 Duke Medical School Classmates Retire After a Combined 100 Years of Patient CareFebruary 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: